Vγ9Vδ2 T cells expressing a BCMA—Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth

Vγ9Vδ2 T cells are immune effector cells capable of killing multiple myeloma (MM) cells and have been tested in clinical trials to treat MM patients. To enhance the MM cell killing function of Vγ9Vδ2 T cells, we introduced a BCMA-specific CAR into ex vivo expanded Vγ9Vδ2 T cells through electroporat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi, Ng, Yu Yang, Du, Zhicheng, Li, Zhendong, Chen, Can, Xiao, Lin, Chng, Wee Joo, Wang, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202950/
https://www.ncbi.nlm.nih.gov/pubmed/35709135
http://dx.doi.org/10.1371/journal.pone.0267475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202950/
https://www.ncbi.nlm.nih.gov/pubmed/35709135
http://dx.doi.org/10.1371/journal.pone.0267475

Ejemplares similares